Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

GlaxoSmithKline Pharmaceuticals Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

21 May 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - GlaxoSmithKline Pharmaceuticals Ltd (GLAXO-IN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

24 May 2016 Thomson Reuters Stock Report 11 $25.00

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Financial and Strategic SWOT Analysis Review

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Financial and Strategic SWOT Analysis Review Summary GlaxoSmithKline Pharma...

10 May 2016 GlobalData 51 $300.00

Wright Investors Service Comprehensive Report for Glaxosmithkline Pharmaceuticals Limited

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

05 May 2016 Wright Reports 56 $75.00

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Financial and Strategic SWOT Analysis Review

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Financial and Strategic SWOT Analysis Review Summary GlaxoSmithKline Pharma...

09 Mar 2016 GlobalData 50 $300.00

MOSL: GSK Pharma 3QFY16 (Neutral)-Profitability disappoints-revenues ahead of estimates

GSK PHARMA 3QFY16: Profitability disappoints; revenues ahead of estimates (GLXO IN, Mkt Cap USD4.0b, CMP INR3239, TP INR3130...

15 Feb 2016 Motilal Oswal Securities Ltd. 10 $104.00

GlaxoSmithkline Pharma (GLXO) - Qtr. Update - Dated - February 11, 2016

GSK Pharma (Bloomberg: GLXO IN; SELL; TP – Rs 2,450; 24% downside from CMP of Rs 3,239) GSK Pharma’s (GSK) Q3FY16 adjusted...

11 Feb 2016 Axis Capital Limited 6 $58.00

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Financial and Strategic SWOT Analysis Review

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Financial and Strategic SWOT Analysis Review Summary GlaxoSmithKline Pharma...

03 Dec 2015 GlobalData 51 $300.00

MOSL: GSK Pharma - Results below estimates - maintain Neutral

GSK Pharma 2QFY16: Results below estimates; maintain Neutral (GLXO IN, Mkt Cap USD4.2b, CMP INR3225, TP INR3020, 6% Downside...

03 Nov 2015 Motilal Oswal Securities Ltd. 10 $92.00

GlaxoSmithkline Pharma (GLXO) - Qtr. Update - Dated - November 02, 2015

GSK Pharma (Bloomberg: GLXO IN; SELL; TP – Rs 2,500; 24% downside from CMP of Rs 3,295) GSK Pharma’s (GSK) revenue decline...

02 Nov 2015 Axis Capital Limited 6 $58.00